IotaMotion的机器人人工耳蜗系统现已获批准适用于4+岁儿童，能够以更高的精度和安全性提升听力效果。 iotaMotion’s robotic cochlear implant system now approved for kids age 4+, improving hearing outcomes with greater precision and safety.

iotamotion已经获得FDA 510(k)许可,将IOTASOFT机器人辅助耳机植入系统扩大到4岁以上儿童,提高精确度,降低内耳结构的风险。 iotaMotion has received FDA 510(k) clearance to expand its iotaSOFT robotic-assisted cochlear implant system to children aged four and older, enhancing precision and reducing risk to inner ear structures. 包括辛辛那提儿童医院在内的美国35个中心目前使用的这项技术显示,85%的听力保存率为一年,超过人工插入率。 The technology, now used at over 35 U.S. centers including Cincinnati Children’s Hospital, shows 85% hearing preservation at one year—surpassing manual insertion rates. 这项进展旨在改善儿科病人的获得机会和结果,支持对语言和语言发展至关重要的早期听力干预。 The advancement aims to improve access and outcomes for pediatric patients, supporting early hearing intervention critical for speech and language development.